Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 291, Issue 4, 2006, Pages

  Anan, Akira ^a   Baskin Bey, Edwina S ^a   Isomoto, Hajime ^a   Mott, Justin L ^a   Bronk, Steven F ^a   Albrecht, Jeffrey H ^b   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Bortezomib; Cellular FLICE inhibitory protein; Cholestasis; Hepatocyte proliferation; Kupffer cells

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BORTEZOMIB; CYCLIN A; CYCLIN D; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; BLOOD SAMPLING; CELL ACTIVATION; CELL PROLIFERATION; CHOLESTASIS; CONTROLLED STUDY; DRUG SYNTHESIS; FIBROGENESIS; GENE TARGETING; HISTOPATHOLOGY; IMMUNOREACTIVITY; KUPFFER CELL; LIVER CELL; LIVER INJURY; MACROPHAGE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BILE DUCTS; BORONIC ACIDS; CELL COUNT; CHOLESTASIS; HEPATOCYTES; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NF-KAPPA B; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES;

EID: 33749442669     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00126.2006     Document Type: Article

References (38)

1. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, and Crary GS. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 16: 2141-2150, 1998.
2. Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, and Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 43: 335-344, 2006.
3. Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 15: 349-356, 2000.
4. Bird MA, Lange PA, Schrum LW, Grisham JW, Rippe RA, and Behrns KE. Cholestasis induces murine hepatocyte apoptosis and DNA synthesis with preservation of the immediate-early gene response. Surgery 131: 556-563, 2002.
5. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, and Gores GJ. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38: 1188-1198, 2003.
6. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, and Gores GJ. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 112: 152-159, 2003.
7. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, and Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123: 1323-1330, 2002.
8. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, and Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83: 655-663, 2003.
9. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, and Karin M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124: 601-613, 2006.
10. Elsharkawy AM, Oakley F, and Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10: 927-939, 2005.
11. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, and Gores GJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103: 137-145, 1999.
12. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, and Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39: 978-983, 2003.
13. Friedman SL and Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem 161: 207-218, 1987.
14. Furuno N, den Elzen N, and Pines J. Human cyclin A is required for mitosis until mid prophase. J Cell Biol 147: 295-306, 1999.
15. Glotzer M, Murray AW, and Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138, 1991.
16. Greim H, Trulzsch D, Roboz J, Dressler K, Czygan P, Hutterer F, Schaffner F, and Popper H. Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 63: 837-845, 1972.
17. Gujral JS, Farhood A, Bajt ML, and Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 38: 355-363, 2003.
18. Gujral JS, Liu J, Farhood A, and Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 40: 998-1007, 2004.
19. Hellerbrand C, Jobin C, Licato LL, Sartor RB, and Brenner DA. Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 275: G269-G278, 1998.
20. Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, and Anderson KC. NF-κB as a therapeutic target in multiple myeloma. J Biol Chem 277: 16639-16647, 2002.
21. Karin M and Lin A. NF-κB at the crossroads of life and death. Nat Immun 3: 221-227, 2002.
22. Kojima Y, Suzuki S, Tsuchiya Y, Konno H, Baba S, and Nakamura S. Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kupffer cells in endotoxin-enhanced reperfusion injury after total hepatic ischemia. Transpl Int 16: 231-240, 2003.
23. Kren BT, Rodrigues CM, Setchell KD, and Steer CJ. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding. Liver Transpl 7: 321-334, 2001.
24. Krueger A, Baumann S, Krammer PH, and Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 21: 8247-8254, 2001.
25. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, and Gores GJ. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol Gastrointest Liver Physiol 272: G1587-G1593, 1997.
26. Lenardo MJ and Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229, 1989.
27. Maher JJ and Neuschwander-Tetri BA. Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis. Hepatology 26: 618-623, 1997.
28. Miyoshi H, Rust C, Guicciardi ME, and Gores GJ. NF-κB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 158: 967-975, 2001.
29. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, and Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117: 669-677, 1999.
30. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, and Su GL. Activation of nuclear factor κ B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30: 934-943, 1999.
31. Pagliari LJ, Perlman H, Liu H, and Pope RM. Macrophages require constitutive NF-κB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol 20: 8855-8865, 2000.
32. Rust C, Karnitz LM, Paya CV, Moscat J, Simari RD, and Gores GJ. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275: 20210-20216, 2000.
33. Souto EO, Miyoshi H, Dubois RN, and Gores GJ. Kupffer cell-derived cyclooxygenase-2 regulates hepatocyte Bcl-2 expression in choledochovenous fistula rats. Am J Physiol Gastrointest Liver Physiol 280: G805-G811, 2001.
34. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, and Thompson RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20: 233-238, 1998.
35. Traenckner EB, Wilk S, and Baeuerle PA. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13: 5433-5441, 1994.
36. Tran-Thi TA, Decker K, and Baeuerle PA. Differential activation of transcription factors NFκB and AP-1 in rat liver macrophages. Hepatology 22: 613-619, 1995.
37. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gabele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, and Thurman RG. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 31: 1544-1549, 2001.
38. Wuestefeld T, Klein C, Streetz KL, Beraza N, Scholmerich J, Burgart LJ, Zender L, Kubicka S, Baskin-Bey E, Gores GJ, Manns MP, and Trautwein C. Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice. Hepatology 42: 1082-1090, 2005.